We identify, analyse and advise
The Swiss National COVID-19 Science Task Force advises the public authorities in the current COVID-19 crisis. While the Task Force does not make decisions about measures or actions taken, the volunteer group of experts represents relevant scientific fields and ensures that impartial scientific advice is given.
The members of the Swiss National COVID-19 Science Task Force do not receive any remuneration or compensation for their work in the Task Force. Each member has disclosed any potential conflicts of interest. These documents are available on the Organisation page.
Overview and evolution of the situation, 17 January 2022
Scientific update of 11 January 2022
Statement Prof. Alain di Gallo, at the Point de presse, 4 January 2022
Wir analysieren die Auswirkungen der Einführung des Covid-Zertifikats im September 2021 in der Schweizer Gastronomie.
Protection duration after vaccination or infection, and efficacy of a third dose by vaccination or booster by infection
People who have recovered from COVID-19 are protected from hospitalization at least as well as people who have received two doses of a mRNA vaccine.
Populated by crowds of young, mobile people gathered in closed spaces for extended periods of time, academic institutions represent a potentially propitious setting for the spread of Sars-CoV-2 both during academic and extracurricular activities.
Since the beginning of the pandemic, thousands of clinical trials assessing therapeutic options for Covid-19 have been included in international registers.